Currently, several countries around the globe are in the high season for respiratory diseases, with various pathogens intertwining and posing significant challenges to clinical diagnosis and scientific research. In response, Turtle Technology, in collaboration with Huashan Hospital, Fudan University, has successfully developed a Single-tube 17-plex Respiratory Pathogen Digital PCR Detection Kit. The kit includes 15 types of viruses and 2 types of bacteria, covering pathogens such as influenza, mycoplasma pneumoniae, adenovirus, human metapneumovirus, and Sars-CoV-2.

This breakthrough achievement is attributed to Turtle Technology's innovative technology—the Exponential Ultra-Multiplex Digital PCR Technology. Compared to the melt curve-based multiplex fluorescence PCR technology, this new technology is of higher level of multiplex, more sensitive, and allows for precise quantification. Additionally, compared to the multiplex digital PCR technology based on the fluorescence probe concentration gradient, the Ultra-Multiplex technology not only detects pathogens and gene types but also achieves high-sensitivity and clinical-level multiplex tumor mutation detection.

Simultaneously, Turtle Technology's propietory SCI Digital series which are equipped with an industrial-leading microfluidic chip and high droplet stability, perfectly complements the Exponential Ultra-Multiplex digital PCR assay kit. The SCI Digital machine not only has a miniaturized design but is also highly automated. Through the combined application of the Single-tube 17-plex Respiratory Pathogen Digital PCR Detection Kit, Turtle Technology has achieved a significant breakthrough in respiratory pathogen detection technology, greatly reducing testing costs and improving efficiency.

In the current rampant situation of respiratory pathogens, Turtle Technology, through the innovation and application of its core technology, benefits more relevant enterprises, clinical institutions, and research organizations. As a high-tech enterprise focusing on upstream life sciences and in vitro diagnostics (IVD), Turtle Technology will continue to empower and support downstream partners through independent innovative technologies like the Exponential Ultra-Multiplex technology. Together, we aim to further popularize digital detection technology in areas such as reagent development, instrument innovation, and testing services.